A prognostic 10‐lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A prognostic 10‐lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients

Published:2019-08-20 Issue:10 Volume:23 Page:6775-6784
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Tang Jianing¹^ORCID,Ren Jiangbo²,Cui Qiuxia¹,Zhang Dan³,Kong Deguang⁴,Liao Xing¹,Lu Mengxin¹,Gong Yan²,Wu Gaosong¹^ORCID

Affiliation:

1. Department of Thyroid and Breast Surgery Zhongnan Hospital of Wuhan University Wuhan China

2. Department of Biological Repositories Zhongnan Hospital of Wuhan University Wuhan China

3. Department of Thyroid and Breast Surgery, Tongji Hospital Huazhong University of Science and Technology Wuhan China

4. Department of General Surgery Zhongnan Hospital of Wuhan University Wuhan China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14556

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Extending Survival with Chemotherapy in Metastatic Breast Cancer

3. Breast cancer as a systemic disease: a view of metastasis

4. Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

5. Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silencing of long noncoding RNA MIAT inhibits the viability and proliferation of breast cancer cells by promoting miR-378a-5p expression;Open Medicine;2023-01-01

2. Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer;Frontiers in Genetics;2022-09-02

3. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer;Pathology and Oncology Research;2022-02-23

4. Modular signature of long non-coding RNA association networks as a prognostic biomarker in lung cancer;BMC Medical Genomics;2021-11

5. Estrogen receptor—positive breast cancer survival prediction and analysis of resistance–related genes introduction;PeerJ;2021-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3